EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+1.73%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$8.15B
AUM Growth
-$196M
(-2.4%)
Cap. Flow
+$63.3M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
27.57%
Holding
907
New
39
Increased
187
Reduced
142
Closed
42
Top Buys
| 1 |
Dollar General
DG
|
$49.2M |
| 2 |
Abbott
ABT
|
$48.4M |
| 3 |
HES
Hess
HES
|
$47.1M |
| 4 |
Progressive
PGR
|
$40M |
| 5 |
Microsoft
MSFT
|
$31.2M |
Top Sells
| 1 |
Netflix
NFLX
|
$71.8M |
| 2 |
PACCAR
PCAR
|
$61.9M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$40.6M |
| 4 |
Biogen
BIIB
|
$34.5M |
| 5 |
Broadcom
AVGO
|
$29M |
Sector Composition
| 1 | Technology | 36.17% |
| 2 | Healthcare | 14.32% |
| 3 | Financials | 13.21% |
| 4 | Communication Services | 10.05% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
HubSpot
HUBS
$25.7B
| $2.34M | 0.03% |
3,299
+19
| +0.6% | +$13.5K |
|
302
EVgo
EVGO
$529M
| $2.32M | 0.03% |
+552,634
| New | +$2.32M |
|
303
Invesco
IVZ
$9.81B
| $2.3M | 0.03% |
130,184
+22,788
| +21% | +$403K |
|
304
Halozyme
HALO
$8.76B
| $2.3M | 0.03% |
47,800
| – | – |
|
305
CBRE Group
CBRE
$48.9B
| $2.3M | 0.03% |
17,600
| – | – |
|
306
Unity
U
$18.5B
| $2.3M | 0.03% |
96,120
-450,000
| -82% | -$10.8M |
|
307
NetEase
NTES
$85B
| $2.29M | 0.03% |
25,000
| – | – |
|
308
Tenaris
TS
$18.2B
| $2.26M | 0.03% |
60,000
| – | – |
|
309
Microchip Technology
MCHP
$35.6B
| $2.25M | 0.03% |
38,516
-29,848
| -44% | -$1.74M |
|
|
BPMC
310
DELISTED
Blueprint Medicines
BPMC
| $2.24M | 0.03% |
25,100
| – | – |
|
311
Natera
NTRA
$23.1B
| $2.24M | 0.03% |
+14,000
| New | +$2.24M |
|
312
American Tower
AMT
$92.9B
| $2.24M | 0.03% |
12,289
+1,505
| +14% | +$274K |
|
313
Equity Residential
EQR
$25.5B
| $2.15M | 0.03% |
30,000
| – | – |
|
314
PVH
PVH
$4.22B
| $2.14M | 0.03% |
19,882
| – | – |
|
315
Manulife Financial
MFC
$52.1B
| $2.13M | 0.03% |
69,300
+400
| +0.6% | +$12.3K |
|
316
Aflac
AFL
$57.2B
| $2.09M | 0.03% |
20,200
-200
| -1% | -$20.7K |
|
317
Warner Bros
WBD
$30B
| $2.05M | 0.03% |
193,220
+17,289
| +10% | +$183K |
|
318
Berkshire Hathaway Class A
BRK.A
$1.08T
| $2.03M | 0.02% |
3
| – | – |
|
319
ConocoPhillips
COP
$116B
| $2.03M | 0.02% |
20,953
-46,147
| -69% | -$4.47M |
|
320
Agilent Technologies
A
$36.5B
| $2.02M | 0.02% |
113,984
| – | – |
|
321
Hologic
HOLX
$14.8B
| $2.01M | 0.02% |
27,629
+129
| +0.5% | +$9.37K |
|
322
United Rentals
URI
$62.7B
| $2M | 0.02% |
2,794
+14
| +0.5% | +$10K |
|
323
Ocular Therapeutix
OCUL
$2.37B
| $1.99M | 0.02% |
235,800
| – | – |
|
324
ChargePoint
CHPT
$239M
| $1.99M | 0.02% |
87,169
-6,618
| -7% | -$151K |
|
|
ITCI
325
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.99M | 0.02% |
23,400
| – | – |
|